<?xml version='1.0' encoding='UTF-8'?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-03-06T02:46:56Z</responseDate>
  <request metadataPrefix="oai_dc" verb="GetRecord" identifier="oai:iwate-u.repo.nii.ac.jp:00015784">https://iwate-u.repo.nii.ac.jp/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:iwate-u.repo.nii.ac.jp:00015784</identifier>
        <datestamp>2023-05-15T12:51:15Z</datestamp>
        <setSpec>1515:1519</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns="http://www.w3.org/2001/XMLSchema" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Calpain-1 C2L domain peptide protects mouse hippocampus-derived neuronal HT22 cells against glutamate-induced oxytosis</dc:title>
          <dc:creator>SUGAWARA, Mayu</dc:creator>
          <dc:creator>ABE, Takumi</dc:creator>
          <dc:creator>KASAI, Shuya</dc:creator>
          <dc:creator>ITOH, Ken</dc:creator>
          <dc:creator>OZAKI, Taku</dc:creator>
          <dc:subject>Mitochondrial calpain-1</dc:subject>
          <dc:subject>Oxytosis</dc:subject>
          <dc:subject>Cell penetrating peptide</dc:subject>
          <dc:subject>Hippocampal HT22 cells</dc:subject>
          <dc:subject>Neurodegeneration</dc:subject>
          <dc:description>Calpains are Ca2+-dependent cysteine proteases; their aberrant activation is associated with several neurodegenerative diseases. The μ-calpain catalytic subunit, calpain-1, is located in the cytoplasm as well as in the mitochondria. Mitochondrial calpain-1 cleaves apoptosis-inducing factor (AIF), leading to apoptotic cell death. We have previously reported that short peptides of calpain-1 C2-like domain conjugated with cell penetrating peptide HIV-Tat (Tat-μCL) selectively inhibit mitochondrial calpain-1 and effectively prevent neurodegenerative diseases of the eye. In this study, we determined whether mitochondrial calpain-1 mediates oxytosis (oxidative glutamate toxicity) in hippocampal HT22 cells using Tat-μCL and newly generated polyhistidine-conjugated μCL peptide and compared their efficacies in preventing oxytosis. TUNEL assay and single strand DNA staining revealed that both μCL peptides inhibited glutamate-induced oxytosis. Additionally, both the peptides suppressed the mitochondrial AIF translocation into the nucleus. All polyhistidine-μCL peptides (containing 4–16 histidine residues) showed higher cell permeability than Tat-μCL. Notably, tetrahistidine (H4)-μCL exerted the highest cytoprotective activity. Thus, H4-μCL may be a potential peptide drug for calpain-1-mediated neurodegenerative diseases such as Alzheimer's disease.</dc:description>
          <dc:description>journal article</dc:description>
          <dc:publisher>Elsevier B.V.</dc:publisher>
          <dc:date>2021-08-12</dc:date>
          <dc:type>VoR</dc:type>
          <dc:format>application/pdf</dc:format>
          <dc:identifier>Biochemistry and Biophysics Reports</dc:identifier>
          <dc:identifier>27</dc:identifier>
          <dc:identifier>101101</dc:identifier>
          <dc:identifier>24055808</dc:identifier>
          <dc:identifier>https://iwate-u.repo.nii.ac.jp/record/15784/files/bbr-v27p101101.pdf</dc:identifier>
          <dc:identifier>https://iwate-u.repo.nii.ac.jp/records/15784</dc:identifier>
          <dc:language>eng</dc:language>
          <dc:relation>info:doi/10.1016/j.bbrep.2021.101101</dc:relation>
          <dc:rights>© 2021 The Authors.</dc:rights>
          <dc:rights>https://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
